Britain's Celltech announced the take-over of fellow biotechnology firm Chiroscience in a surprise deal yesterday to forge a $1 billion biotech giant, the biggest in Europe.

Under the deal, Chiroscience shareholders will be offered 62 new Celltech shares for every 100 shares held. The combined market capitalisation of the group will be around £700 million sterling (€1.07 billion).